While p53 has been long recognised and its role as a tumour suppressor well described,17 efforts to restore its tumour suppressing function have been so far unsuccessful.3 This study shows that there is still an argument for continuing to pursue drugs to successfully modulate this pathway as it appears to have a profound role in PC outcome. The gene discussed is TP53; the disease is pachyonychia congenita.